Sayeh Nikpay, PhD, MPH
Department of Health Policy
Vanderbilt University School of Medicine
Research by health economist Sayeh Nikpay suggests that the 340B program may increase uncompensated care; however, benefits associated with increased safety-net care may be outweighed by an increase in cost sharing among Medicare patients administered 340B-eligible drugs. Hear Nikpay talk about the contributing factors to these study results.
By computer: View the live stream (opens in a new window)
By phone: : #742 829 152
+1 210 606 9466 US Toll
+1 866 282 7366 US Toll Free
Everyone is welcome to attend this seminar. Light refreshments served.